Health-related quality of life analysis in ovarian cancer clinical trials involving Parp inhibitors
A critical methodological perspective
Bibliographic Data
| ID | 15299156 |
|---|---|
| Authors | Frédéric Fiteni (0000-0001-6485-7749, Centre Hospitalier Universitaire de Nîmes, corresponding author), Julien Péron (0000-0002-1709-5152, Hôpital Lyon Sud) |
| Year | 2022 |
| Volume | 31 |
| Issue | 12 |
| Pages | 3331-3337 |
| Publication date | 2022-07-27 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Quality of Life Research (JOURNAL) |
| Journal identifiers | ISSN: 0962-9343 • E-ISSN: 1573-2649 |
| Publisher | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/s11136-022-03193-0 |
| PMID | 35895164 |
| OpenAlex | W4288051620 |
| Language | EN |
| References cited | 16 |
Cancer · Clinical endpoint · Clinical trial · Intensive care medicine · Ovarian cancer · Quality of life (healthcare · Medicine · Nursing · Ovarian cancer diagnosis and treatment · PARP inhibition in cancer therapy · Internal Medicine · Oncology
| Highly cited | No |
|---|